Article Text

Download PDFPDF
Correction of a ‘clarification’


In the issue of 15 February (p. 16) we said that the product licences for two oral contraceptives do not allow their use in post-coital contraception. This is untrue. Product licences issued under the Medicines Act in no way restrict the therapeutic uses of medicines: prescribers are free to use them for any purpose they consider appropriate. We had intended to say that the licences do not allow the manufacturers to promote or otherwise mention the use of their products for post-coital contraception.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.